Francoise Dixon
Head of Investor Relations

Good morning, everyone, and welcome to the Mach7 Q3 FY '26 Results Briefing. My name is Francoise Debelak, and I'm Head of Investor Relations for Mach7. Today, our CEO, Teri Thomas; CFO, Daniel Lee; and EVP, Sales and Marketing, Todd Stallard, will provide an overview of our Q3 results. We will then open it up for questions. [Operator Instructions]

I'll now hand over to Teri.

Teri Thomas
CEO, MD & Director

All right. Thank you, Francoise, and hello. And I want to start by thanking all of you for your continued support of Mach7. I am currently talking with you from Canada, our excellent eUnity development hub and just coming from our new, very entrepreneurial and less expensive office in Vermont. And before that, from visiting KLAS, which is the company that provides customer insights about health technology vendors, which are often referenced by potential buyers globally. KLAS is based in Utah, so I've been on the road a bit.

During this build phase in our strategy, I'm spending the majority of my time in North America. And that's to be with my teams, with customers and with future customers. Very important to be in the field, and I'm showing up myself with energy, urgency and a start-up mindset because this company is a bit like a start-up, but it's coming from an enterprise-grade foundation.

Now we started this reset 6 months ago, and our vision has grown while our costs have reduced. I know our share price volatility has tested some patience, and the market